Sep 23, 4:23 PM ET
On September 21, 2026, Bath & Body Works' compensation committee granted CEO Daniel Heaf a performance stock unit award with a target value of $10 million, equal to 591,366 shares. The award vests only if the average closing stock price over any 60 consecutive trading days reaches $40, $60, $80 or $100 during a four-year performance period, tying a large part of his pay to share price gains.
- Target value of $10 million, equal to 591,366 shares of common stock, granted September 21, 2026 to CEO Daniel Heaf
- Payout ranges from 75% to 200% of target at stock price goals of $40, $60, $80 and $100 over a four-year performance period
- Earned units vest on the fourth anniversary of the grant date, generally subject to continued employment; earned amount is halved if total shareholder return ranks below the 55th percentile of the S&P 1500 Consumer Discretionary Distributio
Read the filing on SEC.gov ↗
Aug 26, 7:17 AM ET
Bath & Body Works reported second-quarter 2026 net sales of $1,514 million, down 2.3% from a year earlier, while diluted earnings per share rose to $0.58 from $0.30. The company raised its full-year 2026 diluted EPS guidance to $3.13 to $3.33 and narrowed its net sales decline forecast to 4% to 2.5%, but the quarter included about $80 million of tariff refunds, and third-quarter EPS guidance of $0.05 to $0.10 is below the $0.37 reported a year earlier.
- Q2 2026 net sales of $1,514 million, down 2.3% from $1,549 million; Direct net sales rose 3.0% to $275 million
- Q2 diluted EPS of $0.58 vs. $0.30; adjusted EPS of $0.62 vs. $0.37. Excluding about $80 million of tariff refunds, adjusted EPS would have been $0.31
- Full-year 2026 diluted EPS guidance raised to $3.13 to $3.33; adjusted EPS guidance $2.60 to $2.80; net sales guidance narrowed to a decline of 4% to 2.5%
- Q3 2026 diluted EPS guidance of $0.05 to $0.10 (adjusted $0.07 to $0.12) vs. $0.37 (adjusted $0.35) in Q3 2025
Read the filing on SEC.gov ↗
May 27, 7:12 AM ET
Bath & Body Works reported first quarter 2026 net sales of $1,378 million, down 3% from a year earlier, and reaffirmed its full-year 2026 guidance. Reported earnings per diluted share rose to $0.90 from $0.49, but that figure includes an $88 million pre-tax litigation settlement gain and a $62 million tax benefit, while adjusted EPS was $0.32 versus $0.49 last year. Chief Financial Officer Eva Boratto will step down June 12, and Tom Javitch will serve as interim CFO while the company searches for a successor.
- Q1 2026 net sales were $1,378 million, down 3% from $1,424 million in Q1 2025.
- Reported diluted EPS was $0.90 versus $0.49; adjusted diluted EPS was $0.32 versus $0.49.
- Full-year 2026 guidance reaffirmed: net sales down 4.5% to 2.5%, adjusted diluted EPS $2.40 to $2.65.
- Second-quarter 2026 diluted EPS is expected at $0.20 to $0.25; CFO Eva Boratto steps down June 12 and Tom Javitch becomes interim CFO.
Read the filing on SEC.gov ↗
Mar 4, 7:17 AM ET
Bath & Body Works reported fourth-quarter 2025 net sales of $2,724 million, down 2%, and diluted EPS of $1.99 versus $2.09 a year earlier. It guided fiscal 2026 net sales down 4.5% to 2.5% and adjusted diluted EPS of $2.40 to $2.65, compared with adjusted EPS of $3.21 in 2025, which signals lower profit for shareholders.
- Q4 2025 net sales were $2,724 million, down from $2,788 million; operating income was $599 million versus $678 million.
- Q4 2025 diluted EPS was $1.99 ($2.05 adjusted), compared with $2.09 a year earlier.
- Full-year 2026 guidance: net sales down 4.5% to 2.5%; adjusted diluted EPS of $2.40 to $2.65, compared with $3.21 in 2025.
- Company expects free cash flow of approximately $600 million in fiscal 2026 and assumes no share repurchases.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.